Skip to Content
Merck
CN

P3B030A00

Millipore

Pellicon® 3 Cassette with Biomax® Membrane

30kDa, A Screen, 88 cm2

Synonym(s):

Pellicon® 3 Cassette with Biomax® 30 kDa Membrane, A Screen, 88cm2

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
23151806
eCl@ss:
32031623
NACRES:
NB.24

material

TPE seal
polyethersulfone membrane (void free)
polypropylene
polypropylene cap (for end)
polypropylene screen

Quality Level

feature

holdup volume 1.8 mL (in feed channel)

manufacturer/tradename

Pellicon®

parameter

30 psi max. reverse press. exposure at 25 °C (for 24 hours)
4-6 L/min-m2 recirculation rate
40 psi max. transmembrane pressure at 4-50 °C
6.9 bar max. inlet pressure (100 psi)
80 psi max. transmembrane pressure at 4-40 °C

technique(s)

buffer exchange: suitable
protein purification: suitable (concentration)

H

0.8 cm (0.33 in.)

L

20.6 cm (8.1 in.)

W

5.6 cm (2.2 in.)

filtration area

88 cm2

membrane area

88 cm2

gravimetric extractables

≤1500 mg/m2

matrix

Biomax® (Membrane)

pore size

30 kDa NMWCO

pH

1-14

shipped in

ambient

Looking for similar products? Visit Product Comparison Guide

General description

Pellicon® 3 filtration devices are advanced, high-performance cassettes ideal for today’s higher titer therapeutic antibodies as well as the more demanding filtration processes that require higher operating pressures, temperatures and caustic cleaning regimes.

The Pellicon® 3 Cassette with Biomax® Membrane is perfect for the filtration of monoclonal antibodies and solutions containing albumin, hormones, vaccines and growth factors.

This P3B030A00 Pellicon® 3 ultrafiltration device features a pore size of 30 kDa NMWCO, a filtration area of 88 cm2, a Biomax® 30 membrane, and dimensions measuring 0.8 cm (H) x 5.6 cm (W) x 20.6 cm (L).

Features and Benefits

  • Rugged & reliable – ideally suited for today′s more demanding filtration processes
  • High performance – produces excellent resolution, yields and back-pressure resistance
  • Optimum product recovery – thanks to proven membrane technology
  • Void-free technology – leading-edge membranes resolve virtually any separation challenge
  • Defect-free, superior adhesion – Ultracel®uses composite membranes cast on a microporous substrate
  • Automated manufacturing – delivers unbeatable performance, consistency and reliability
  • Easy installation & care – simple to install and maintain

Other Notes

These products are manufactured in a facility which adheres to FDA Good Manufacturing Practices.

Analysis Note

Gravimetric Extractables: after 24 hours in water at controlled room temperature

Legal Information

BIOMAX is a registered trademark of Merck KGaA, Darmstadt, Germany
Pellicon is a registered trademark of Merck KGaA, Darmstadt, Germany
ULTRACEL is a registered trademark of Merck KGaA, Darmstadt, Germany

WGK

WGK 1


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Articles

Learn more one the attenuated viral vaccines manufacturing process: cell culture, clarification, nuclease treatment, chromatography, and sterile filtration.

Related Content

This page summarizes key considerations related to regulatory expectations for biomanufacturing including chemicals and polymeric materials. For chemicals, topics include nitrosamines and elemental impurities, and for polymeric materials such as filters and single-use assemblies, the focus is qualification and extractable and leachable testing.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service